Neumora Therapeutics Inc (NMRA)

04:06 AM

Published on: 2025-08-15 11:05:55 - beatles.ru

04:06 AM

Aug 14, 2025

Federated Hermes Inc. Invests $285,000 in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

Aug 14, 2025

Aug 14, 2025

Research Analysts Issue Forecasts for NMRA Q3 Earnings - MarketBeat

Aug 14, 2025

Aug 14, 2025

William Blair Has Positive Forecast for NMRA Q3 Earnings - MarketBeat

Aug 14, 2025

Aug 14, 2025

XTX Topco Ltd Raises Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

Aug 14, 2025

Aug 12, 2025

William Blair Has Positive Estimate for NMRA FY2029 Earnings - MarketBeat

Aug 12, 2025

Aug 11, 2025

Neumora's Q2 2025 Earnings Call: Unpacking Key Contradictions in M4 PAM Safety, Obesity Focus, and KOASTAL Studies - AInvest

Aug 11, 2025

Aug 10, 2025

Neumora Therapeutics reports Q2 EPS (33c), consensus (37c) - MSN

Aug 10, 2025

Aug 08, 2025

Elevidys sales weaken; Neumora gets into obesity - BioPharma Dive

Aug 08, 2025

Aug 08, 2025

Neumora Therapeutics Faces Challenges as It Transitions to Full Public Company Compliance - TipRanks

Aug 08, 2025

Aug 07, 2025

Neumora Therapeutics’ Earnings Call Highlights Promising Pipeline - TipRanks

Aug 07, 2025

Aug 07, 2025

Neumora outlines six upcoming clinical catalysts and prioritizes obesity program with NMRA-215 - MSN

Aug 07, 2025

Aug 07, 2025

Stifel maintains Hold rating on Neumora Therapeutics stock at $2.00 By Investing.com - Investing.com Canada

Aug 07, 2025

Aug 07, 2025

Promising Developments and Pipeline Progress Drive Buy Rating for Neumora Therapeutics - TipRanks

Aug 07, 2025

Aug 07, 2025

Neumora Therapeutics, Inc.: Promising Potential in Obesity Therapeutics with NMRA-215 - TipRanks

Aug 07, 2025

Aug 07, 2025

Earnings call transcript: Neumora Therapeutics beats Q2 2025 EPS estimates - Investing.com

Aug 07, 2025

Aug 07, 2025

Neumora Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 07, 2025

Aug 06, 2025

Neumora Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025

Aug 06, 2025

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Aug 06, 2025

Aug 04, 2025

Neumora Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView

Aug 04, 2025

Aug 04, 2025

Quant Models Detect Momentum Reversal in Neumora Therapeutics Inc.High Accuracy Alerts for ROI Traders Detected - beatles.ru

Aug 04, 2025

Aug 03, 2025

How volatile is Neumora Therapeutics Inc. stock compared to the marketUnprecedented market success - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Why is Neumora Therapeutics Inc. stock attracting strong analyst attentionSignificant capital appreciation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does Neumora Therapeutics Inc. stock perform well during market downturnsCapitalize on fast-growing stocks today - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Neumora Therapeutics Inc. generate profit in a changing economyCapitalize on market trends with expert guidance - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Neumora Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What institutional investors are buying Neumora Therapeutics Inc. stockAchieve triple-digit returns with smart investing - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What are the latest earnings results for Neumora Therapeutics Inc.Capitalize on market momentum for maximum profit - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Neumora Therapeutics to Report Q2 2025 Financial Results on August 6, 2025 - AInvest

Aug 02, 2025

Aug 02, 2025

What are analysts’ price targets for Neumora Therapeutics Inc. in the next 12 monthsAI Powered Tips With High Returns - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Neumora Therapeutics (NMRA) Projected to Post Earnings on Wednesday - MarketBeat

Aug 02, 2025

Aug 02, 2025

How strong is Neumora Therapeutics Inc. company’s balance sheetExpert Picks Entry Points For 2025 - Jammu Links News

Aug 02, 2025

Aug 01, 2025

What is the dividend policy of Neumora Therapeutics Inc. stockPost Market Planner That Work - Jammu Links News

Aug 01, 2025

Aug 01, 2025

How many analysts rate Neumora Therapeutics Inc. as a “Buy”Chart Pattern Updates For Fast Growth - Jammu Links News

Aug 01, 2025

Aug 01, 2025

What are the technical indicators suggesting about Neumora Therapeutics Inc.Chart Pattern Guidance To Watch Now - Jammu Links News

Aug 01, 2025

Aug 01, 2025

Key metrics from Neumora Therapeutics Inc.’s quarterly dataTrade Insight With Community Collaboration Supported - metal.it

Aug 01, 2025

Aug 01, 2025

Earnings Preview: NMRA to Report Financial Results Post-market on August 06 - 富途牛牛

Aug 01, 2025

Jul 31, 2025

What are Neumora Therapeutics Inc. company’s key revenue driversAI Powered Planner Backed By Experts - Jammu Links News

Jul 31, 2025

Jul 30, 2025

Why Neumora Therapeutics Inc. stock attracts strong analyst attentionStrong Buy With Technical Confidence Supported - beatles.ru

Jul 30, 2025

Jul 30, 2025

Published on: 2025-07-30 12:15:41 - metal.it

Jul 30, 2025

Jul 29, 2025

Mizuho Raises Price Target for Neumora (NMRA), Keeps Outperform Rating - MSN

Jul 29, 2025

Jul 29, 2025

Mizuho Boosts Neumora Price Target to $5, Maintains Outperform Rating - AInvest

Jul 29, 2025

Jul 29, 2025

Pegasystems Delivers Strong Q2 Results, Raises Price Target to $58 - AInvest

Jul 29, 2025